XML 158 R130.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-based Compensation Plans (Narrative) (Details)
$ in Millions
12 Months Ended
Jun. 03, 2016
shares
Dec. 31, 2017
USD ($)
£ / shares
shares
Dec. 31, 2017
USD ($)
shares
Dec. 31, 2016
USD ($)
£ / shares
shares
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2015
USD ($)
£ / shares
Dec. 31, 2015
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share-based compensation expense | $     $ 174.9   $ 318.5   $ 100.3
Unrecognized compensation cost relating to non-vested awards | $   $ 218.3 $ 218.3 $ 244.2 244.2 $ 115.3 115.3
Unrecognized compensation cost relating to non-vested awards, expected period for recognition     3 years        
Intrinsic values of share-based awards exercised | $   $ 147.1 $ 147.1 $ 214.6 214.6 $ 198.8 198.8
Proceeds from issuance of stock for share-based compensation arrangements | $     134.1   169.2   16.6
Tax benefit associated with exercise of stock options | $     $ 0.0   $ 8.8   31.6
Forfeiture rate     0.00%        
SARs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Expiration period     7 years        
RSUs, PSUs and PSAs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Additional holding period after vesting     2 years        
Vesting period     3 years        
Outstanding (in shares)   3,959,720 3,959,720        
Granted (in shares)     2,520,239        
Outstanding (in shares)   3,959,720 3,959,720 3,976,657 3,976,657    
Stock-settled SARs and stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)     9,865,956        
Outstanding (in shares)   25,618,821 25,618,821 21,869,833 21,869,833    
Exercisable (in shares)   13,329,159 13,329,159        
Weighted average grant date fair value (in GBP per share) | £ / shares   $ 9.72   $ 8.25   $ 10.36  
Baxalta | Baxalta Replacement Award              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Share-based compensation expense | $     $ 61.6   $ 223.1   0.0
Integration related costs | $     $ 14.8   $ 171.0   $ 0.0
Baxalta | Baxalta Replacement Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Expiration period     10 years        
Outstanding (in shares)   9,425,001 9,425,001        
Baxalta | Baxalta Replacement RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Expiration period     3 years        
Outstanding (in shares)   701,340 701,340        
Portfolio Share Plan Part | SARs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Expiration period     7 years        
Outstanding (in shares)   15,693,527 15,693,527        
Sharesave Scheme | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Expiration period     6 months        
Outstanding (in shares)   184,647 184,647        
Employee Stock Purchase Plan | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Exercise price of common stock, percent     85.00%        
Savings period     12 months        
Outstanding (in shares)   315,646 315,646        
United Kingdom | Sharesave Scheme | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Exercise price of common stock, percent     80.00%        
Ireland | Sharesave Scheme | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Exercise price of common stock, percent     75.00%        
Minimum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Forfeiture rate     0.00%   5.00%   5.00%
Minimum | Sharesave Scheme | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Minimum | Employee Stock Purchase Plan | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     1 year        
Maximum              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Forfeiture rate     0.00%   7.00%   7.00%
Maximum | Sharesave Scheme | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     5 years        
Maximum | Employee Stock Purchase Plan | Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     5 years        
Executive Directors | Portfolio Share Plan Part | SARs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period     3 years        
Baxter Employees | RSUs, PSUs and PSAs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares) 500,000            
Outstanding (in shares)   0 0        
Baxter Employees | Stock-settled SARs and stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares) 8,800,000            
Outstanding (in shares)   6,200,000 6,200,000        
Exercisable (in shares)   6,200,000 6,200,000        
EBT | Common stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Treasury stock held (in shares)   500,000 500,000        
EBT | ADS              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Treasury stock held (in shares)   200,000 200,000        
Year 1 | Baxalta | Baxalta Replacement Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%        
Year 1 | Baxalta | Baxalta Replacement RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%        
Year 2 | Baxalta | Baxalta Replacement Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%        
Year 2 | Baxalta | Baxalta Replacement RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%        
Year 3 | Baxalta | Baxalta Replacement Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%        
Year 3 | Baxalta | Baxalta Replacement RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting percentages     33.33%